Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention
about
JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms.Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.Treatment options for essential thrombocythemia and polycythemia vera.Special issues in myeloproliferative neoplasms.Pathophysiology of acquired von Willebrand disease: a concise review.BCR-ABL1-negative chronic myeloid neoplasms: an update on management techniques.Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms.The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience.Preservation of small bowel with the selective use of heparin and second look laparotomy in acute mesenteric ischaemia: A case report.Superior vena cava syndrome in a patient with polycytemia vera: diagnosis and treatment.Treatment related changes in antifibrinolytic activity in patients with polycythemia vera.Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.Global coagulation in myeloproliferative neoplasms.Anesthetic management of a patient with polycythemia vera for neurosurgery.Perioperative blood product administration and thromboembolic events in patients with treated polycythemia vera: a case-control study.JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance
P2860
Q30572002-EA578BFD-AF25-48AF-8205-3FCBD382EFE5Q34840082-67B3C698-2CA1-411D-B050-54C0C970A350Q37672905-4CF5C397-D1FC-4ED1-AC29-E79F95673B50Q37810107-A78D5468-22AA-4B41-9DBA-AB6285AB575CQ37823434-2A56C563-47A1-42AF-98CD-C4B5E74A5B5AQ37870983-25E90027-278C-4033-BFFE-CA760C3D2BD6Q38014534-2ABDA8C3-9881-4A9E-8CB1-6FF6283E576EQ38187674-A3288AD4-8050-44EA-8D37-8D058EA08ED7Q39199539-347809C6-FD0D-4CFC-B0BC-5D1E3FE43A60Q40074413-3116A32D-C293-4618-AED6-733EED34A280Q42175338-5EC8E2FE-3DFE-4119-AEF6-262F0E70B81FQ42738509-708BBE8C-CEA1-4DF7-B46A-4227D0EAAC2EQ42790714-CA0040F0-E0EF-43F8-A6AA-02216030A159Q43213477-6ED34E89-D8F4-41C0-B470-8FF3A6DD1327Q43451935-B5755D42-C653-4612-95C6-083F8DF889FEQ44345261-D8533708-ED16-4DFF-BC9C-822A7C5391E1Q45710734-0725D2AE-BEC3-45DA-90B1-81AB5FBF6E8AQ45723065-95EF3E9E-008B-4479-8EBE-1FD40902AEA7Q47417130-18B1B770-8C60-476E-BF4F-1C4AFBF780B9Q47741741-15D68364-AEC0-470C-9DF6-AD63759212B9Q50453793-86472920-83DE-4AFE-8396-F0BACF66A4B5Q54394284-DD005CCF-A5C4-469C-AA5E-4E050AFA26F7Q58587352-2BBFB27A-B6D7-4E7C-8A40-C454790E9423
P2860
Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@ast
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@en
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@nl
type
label
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@ast
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@en
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@nl
prefLabel
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@ast
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@en
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@nl
P1476
Thrombosis and bleeding in pol ...... etic mechanisms and prevention
@en
P2093
Linda Novarese
Maria Celeste Cipriani
P304
P356
10.1016/J.BEHA.2005.07.011
P407
P577
2006-01-01T00:00:00Z